Provisions for the Pharmaceutical Services Committee of Inquiry have been included within the National Health Act for some time. The Act allows that the Committee can be established at either a state or federal level. State level committees were last active approximately 20 years ago. A growing number of complaints regarding the conduct of approved pharmacists in relation to the supply and claiming of Pharmaceutical Benefits Scheme medicines from premises for which the pharmacists were not approved prompted the previous Minister for Health to direct the Department to re-establish the Committee. This will allow the committee to investigate matters, at a federal level, of non-compliance with conditions of approval for approved pharmacists. It is for this reason the Pharmaceutical Services Federal Committee of Inquiry has been established. The National Health Act specifies the membership of the committee to consist of four pharmacists to be appointed by the Minister for Health as well as the Secretary (or their delegate who must be a Departmental officer who is a medical practitioner or pharmacist).

Further information

  • Type of Body

    E. Statutory Office Holder Offices and Committees

  • Established By / Under

    Act / Regulation

  • Established By/Under More info

    National Health Act 1953

  • Paid Members?


  • Max No. of Board/Committee Members


  • Annual Report Prepared and tabled?


  • Classification

    B. Secondary

  • Function Categorization

    Regulatory / Review / Inquiry / Commission

  • Creation Date

    20 April 2015

Current board appointments

Position Appointee Start Date End Date
Member Ms Ms. Juliana Sestan 20 April 2021 Determined by the appointer
Member Ms. Renae Beardmore 20 April 2021 Determined by the appointer
Member Ms. Helen Dowling 20 April 2021 Determined by the appointer
Member Mr. Peter Downing 1 March 2020 Determined by the appointer
Last updated: